A case of advanced gynecologic pelvic tumors showing the diagnostic utility of HPV analysis
Authors:
Open Access
- 1 January 2009
- journal article
- Published by Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy in Journal of Gynecologic Oncology
- Vol. 20 (4) , 251-3
Abstract
Gynecologic malignancies may have similar histological characteristics. This may lead to difficulties in determining the origin of the cancer and to distinguish a synchronous neoplasm from a metastatic cancer in advanced cases. Recently, we treated a 59-year-old patient with adenocarcinoma of the uterine cervix, endometrium, fallopian tubes, and ovaries. It was difficult to determine whether the cancer was a single origin metastatic cancer or a synchronous neoplasm. The patient was finally diagnosed with metastatic cancer that originated from the uterine cervix by human papillomavirus (HPV) test. Here we report the case and briefly review of the medical literature.Keywords
This publication has 10 references indexed in Scilit:
- Synchronous and Metachronous Endocervical and Ovarian NeoplasmsAmerican Journal of Surgical Pathology, 2005
- The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: A new diagnostic approachInternational Journal of Oncology, 2004
- Utility of HPV Analysis for Evaluation of Possible Metastatic Disease in Women With Cervical CancerInternational Journal of Gynecological Pathology, 2004
- Detection of human papillomavirus-16 in ovarian malignancyBritish Journal of Cancer, 2003
- Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development.Tumor Biology, 2003
- Metastatic endocervical adenocarcinoma presenting as a virilizing ovarian mass during pregnancyObstetrics & Gynecology, 2002
- Detection of Human Papillomavirus DNA in Malignant Lesions from Chinese Women with Carcinomas of the Upper Genital TractGynecologic Oncology, 2002
- Prospective Study of Antibody to Human Papilloma Virus type 16 and Risk of Cervical, Endometrial, and Ovarian Cancers (United States)Cancer Causes & Control, 2001
- The role of human papillomavirus in cervical adenocarcinoma carcinogenesisEuropean Journal of Cancer, 2001
- Failure to Demonstrate Human Papillomavirus DNA in Epithelial Ovarian Cancer by General Primer PCRGynecologic Oncology, 1999